Progress in Immunotherapy
Thanks to the hard work of researchers, we're getting smarter about cancer. Right now, we're finding ways to use the body's own immune system to manipulate genes to solve cancer's puzzle.
The Mass General Cancer Center is an authorized treatment center for two FDA approved CAR T-cell therapies for adult patients with lymphoma, Yescarta and Kymriah.
The Center for Cancer Immunology’s investigators are working to expand the use of immunotherapy, a revolutionary approach to cancer therapy.
Severe Immunotherapy Complications Service
The Severe Immunotherapy Complications Service and Clinical-Translational Research Effort Program is working to address the urgent need to understand how and why immune-related adverse events occur.
What is Immunotherapy?
Immunotherapy is a type of cancer treatment that uses the body’s immune system to find and attack cancer cells.
Immune therapy takes a "BiTE" out of brain cancer
A method combining two distinct immune system-based treatments may help to improve outcomes for patients with glioblastomas and other solid tumors.
A Novel CAR T-Cell Therapy for Multiple Myeloma
In this new study published in NEJM, Noopur Raje, MD et al. report the initial toxicity profile of a BCMA-directed cellular immunotherapy for patients with relapsed or refractory multiple myeloma.
Beating Resistance to Immunotherapy in Metastatic Melanoma
In this article and companion podcast, learn how Dr. Nir Hacohen’s lab works to understand the mechanisms underlying resistance to immune checkpoint blockade therapy in metastatic melanoma, and how the lab is setting the ground work for two potential new therapies.
Nir Hacohen, PhD
Our goal is to understand how immune responses against tumors are initiated, maintained and evaded, with the hope of improving the ability of the immune system to eradicate cancer.
Director, Center for Cancer Immunology, Mass General Cancer Center